XML 40 R33.htm IDEA: XBRL DOCUMENT v3.24.3
Stockholders' Equity (Additional Information) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 9 Months Ended
May 30, 2024
Sep. 30, 2024
Sep. 30, 2024
Sep. 30, 2023
Jun. 20, 2024
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Options vested, fair value     $ 3,600 $ 4,000  
Authorized shares under the plan (in shares)   8,150,000 8,150,000   8,150,000
Granted (in shares) 1,697,712        
Stock repurchased and retired during period, shares (in shares) 1,697,712        
Shares acquired, average cost per share (in dollars per share) $ 3.51        
Share-based compensation arrangement by share-based payment award, options, grants in period, weighted average grant date fair value (in dollars per share) $ 3.51        
Proceeds from sale of common stock and warrants, net   $ 7,400 $ 9,232    
Sale of Stock, Number of Shares Issued in Transaction   3,100,000 3,900,000    
Equity Incentive Plan 2021          
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Number of remaining shares available for issuance (in shares)   3,155,783 3,155,783    
Options to purchase Common Stock          
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Unrecognized compensation cost   $ 8,100 $ 8,100    
Weighted-average remaining vesting period for recognition     2 years 4 months 24 days    
Options outstanding, weighted average contractual life     7 years 8 months 12 days    
Granted (in shares)     1,899,096    
Inducement Grant Stock Options          
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]          
Granted (in shares)     1,380,248